A. Aoyagi

A Solid Tumor of Donor Cell‐Origin After Allogeneic Peripheral Blood Stem Cell Transplantation

T. Yamagata, K. Mitani, Y. Imai, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Direct evidence of altered bone metabolism caused by all-trans retinoic acid

S. Ishikawa, H. Akiyama, S. Nagasaka, 2005, Journal of Bone and Mineral Metabolism.

Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study.

K. Saito, H. Sakuma, S. Furusawa, 1995, Leukemia.

Successful HLA-identical Unrelated Allogeneic Bone Marrow Transplantation with a very Low Dose of Stem Cells for a Patient with Chronic Myeloid Leukemia in Blast Crisis

K. Mitani, K. Maki, Yuichi Nakamura, 2002, Leukemia & lymphoma.

Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia wit

K. Saito, W. Takahashi, Y. Nakamura, 2000, International journal of hematology.

[Comparison of low-dose cytosine arabinoside and aclarubicin in combination with granulocyte colony-stimulating factor to intermediate-dose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia].

K. Saito, S. Furusawa, M. Noguchi, 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Preferential inhibitory effect of soluble factor(s) in human bone marrow stromal cells on proliferation of K562 leukemia cells versus normal myeloid progenitor cells.

H. Enokihara, S. Furusawa, K. Waga, 1996, International journal of hematology.